|
Wheelchair-bound multiple sclerosis patient
Richard Paey is serving 25 years in a Florida prison for “trafficking" 1/2 gram
of OxyContin, even though the prosecutor concedes that Paey never sold any of
his medications. In prison, he now receives more pain-killing drugs than he was
convicted of having.
Dr. William Hurwitz, a pioneering pain physician, was tried and convicted of
violating the Controlled Substances Act -- which is intended to curb the illicit
use of drugs -- and is serving a 25-year term in federal prison. He was also
fined $2 million.
These are but two of hundreds of cases in which, in its zeal to stamp out the
illegal drug use, the U.S. Drug Enforcement Administration (DEA) is cracking
down on doctors who prescribe medications to relieve chronic pain, and the
patients who depend on these drugs to live normal lives.
Hundreds of physicians have been put on trial for charges ranging from health
insurance fraud to drug distribution, even to manslaughter and murder for
over-prescribing prescription narcotics. Investigators have also seized doctors’
homes, offices, and bank accounts, leaving them with no resources for their
defense.
In March 2004, DEA administrator Karen Tandy told Congress her drug warriors
have "been successful in addressing OxyContin diversion as evidenced by a
reduction in the rate of increase of OxyContin prescriptions being written and a
leveling-off of OxyContin sales." But Ronald Libby, a professor of political
science at the University of North Florida, told us he doubts that sales of
opioids like Oxycodone have declined since 2004.
Drug diversion means the diversion of legal drugs for illicit purposes.
Prescription drug abuse accounts for almost 30% of the overall drug problem in
the United States, representing a close challenge to cocaine addiction.
Sometimes these diverted prescription drugs end up for sale on the street, where
they reap large profits for traffickers.
Starting in the mid-1990s, and ratcheting up in 2001, the DEA -- part of the
U.S. Department of Justice (DOJ) -- has been leading an aggressive effort to
eradicate the illegal "diversion" of certain prescription painkillers. A
particular target has been OxyContin, one of a class of drugs known as opioids,
which was aggressively marketed by its manufacturer, Purdue Pharma.
In 2001, the DEA launched a campaign called the "OxyContin Action Plan". The DEA
says the plan is necessary due to increasing abuse of prescription drugs,
particularly by youth. The agency, which has teamed up with state and local
authorities, typically employs law enforcement methods developed in the
government’s “War on Drugs", including aggressive undercover investigation,
asset forfeiture, and informers. It says its goal is to stop violations of the
Controlled Substances Law.
But critics charge that the DEA has focused too narrowly on doctors,
exacerbating the already widespread problem of untreated or under-treated pain.
As a result, well-meaning doctors are finding themselves subject to costly,
potentially career-ending investigations. Several doctors and many of their
patients have already been sent to prison.
The DEA maintains that only “criminal doctors" are being targeted, and that its
efforts to prevent the sale of prescribed medications have no effect on the
legitimate treatment of pain.
The pain-management community disagrees. Authorities say the DEA program
reportedly is having a chilling effect on physicians, who are leaving their pain
management specialties for safer practices, and on their patients, many of who
literally cannot function without medication. The Village Voice newspaper
reports that medical schools are now advising students to avoid pain management
practice altogether.
Ironically, the DEA crackdown comes at a time when the medical profession knows
more than ever about how to treat the chronic pain that makes life intolerable –
sometimes impossible – for the estimated 50 to 70 million Americans who live in
chronic disabling pain.
Until about 20 years ago, the medical profession knew little about pain
management. Today, pain management has become a recognized medical specialty,
and it is estimated that there are some 5,000 pain management doctors practicing
in the U.S.
The DEA’s programs also come at a time when there are more effective
pain-killing drugs on the market and when the Internet makes it easier than ever
to obtain them.
The DEA’s dilemma is separating legitimate prescribers and users from drug
dealers. And the DEA’s task is made more difficult, not only by its zeal, but by
the fact that those investigating and prosecuting are not doctors but lawyers
and law enforcement agents.
Before he was ever charged with a crime, Dr. Hurwitz recommended that the DEA
“suspend current prosecutions against physicians who treat pain unless and until
a review by a panel of nationally recognized experts in medical pain management
has found that there is an absence of good faith by the physician. If only the
physician's adherence to standards of care can be questioned, then the case is
not an appropriate one for the criminal process, and should be referred to the
professional regulatory authorities," he said.
The Association of American Physicians and Surgeons, in a letter to the judge in
the Hurwitz case, charged he was convicted on the basis of “false expert
testimony", which it described as “egregious."
Their letter said, “That a tiny percentage of his patients then broke the law
with their prescriptions does not justify imprisoning Dr. Hurwitz for the rest
of his life. A conviction based on this false medical testimony should not
stand…."
The Hurwitz situation is not isolated. Throughout the U.S., physicians have been
prosecuted, jailed, or have lost their licenses to practice medicine. In
addition to Hurwitz, Dr. Ronald McIver is serving 30 years, Dr. Freddie Williams
is serving life, and Dr. James Graves received a 62-plus-year sentence for
diversion in 2002.
According to Prof. Libby, who has become an authority on the subject, “Many
doctors have been convicted and almost no one has been acquitted." He told us,
“Most attorneys tell their clients to cop a plea and not fight it in court."
Richard Paey was convicted of fraudulently submitting multiple copies of opioid
prescriptions to treat chronic pain. He was in New Jersey where his doctor
treated him, but then moved to Florida where he was unable to find a physician
to write prescriptions to treat his pain.
Frightened by what they term a “brutal display of executive power", most
doctors, including those in the field of pain management, have simply abandoned
this sickest and most vulnerable segment of our population. Patients suffering
from mild to moderate pain, and requiring low dosages of opioids may still find
care, but those patients with high dosage requirements are increasingly shut out
of care altogether.
In 2004 it was estimated that many of the 5,000 pain specialists in the United
States, would not prescribe opioids. Those few medical practices that do treat
chronic pain with opioids impose severe restrictions on patients’ freedoms.
Prof. Libby told us that many doctors are now prescribing over-the-counter
medications such as aspirin and Tylenol, “which are far more dangerous than
opioids if taken in large quantities."
The DEA claims it investigates less than one per cent of physicians who
prescribe OxyContin or other drugs covered by the Controlled Substances Act. The
agency reported arresting 34 doctors out of 963,385 registered doctors in 2003,
for selling opioids to addicts or drug dealers for money, sex, or favors. That
is less than 0.001% of the total number of licensed doctors, the DEA said.
But critics dispute that figure. Prof. Libby told us, “In 2001, the DEA carried
861 investigations of doctors. If we use this figure instead of 34 arrests it
means that more than 17 percent of the roughly 5,000 doctors who treat pain
patients were investigated. That means that than one out of every six doctors
who treat chronic pain patients were under criminal investigation."
A not-for-profit advocacy group, the Pain Relief Network, is suing to have the
Controlled Substances Act declared unconstitutional, and is seeking to enjoin
the DEA from enforcing the law against physicians.
To calm its critics, the DEA commissioned several pain specialists to work with
Federal officials to create guidelines for physicians who treat pain with
opioids. These guidelines were posted on the agency's website, and most doctors
were led to believe that following the recommendations would keep them safe from
prosecution.
But that understanding didn't last long. Late last year the guidelines were
taken off the DEA's website. The agency claimed it wasn't bound by any standards
or practices when it came to determining what physicians it would investigate.
Removal of the guidelines coincided with Dr. Hurwitz’s trial. The doctor’s
attorneys attempted to have the guidelines admitted as evidence on the belief
that Hurwitz's practice conformed to their parameters. They failed. A few weeks
after Hurwitz's judge refused to admit the guidelines as evidence, the DEA
renounced them, and essentially declared it had carte blanche to launch an
inquiry.
David Joranson, the academic pain specialist who headed the committee that
authored the original guidelines, sent the agency a sharply-worded rebuke. Three
other professional associations representing pain specialists followed with a
second letter. And the National Association of state Attorneys General wrote to
the DEA, expressing concern that the agency was overstepping its bounds and
interfering with the legitimate treatment of pain. The letter was signed by 30
AGs from both parties.
However, the DEA remains unmoved, insisting its revocation of the guidelines did
not represent a shift in policy and that its pursuit of doctors should have no
effect on legitimate pain treatment.
Alexander DeLuca, M.D., MPH, a Board Member of the Pain Relief Network, told us,
"Relations between physicians and the DEA have probably never been worse in
modern times."
He added, "Law enforcement does not deserve a place at the table where
physicians, social workers, and politicians of good will need to meet to deal
with drug use and pain problems as public health, not criminal, matters."
Author's bio:
William Fisher has managed
economic development programs in the Middle East and elsewhere for the US State
Department and the US Agency for International Development. He served in the
international affairs area in the Kennedy Administration and now writes for
InterPress News Service.
See also:
http://billfisher.blogspot.com
[END]
|